1. Home
  2. EDSA vs SSKN Comparison

EDSA vs SSKN Comparison

Compare EDSA & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SSKN
  • Stock Information
  • Founded
  • EDSA 2015
  • SSKN 1989
  • Country
  • EDSA Canada
  • SSKN United States
  • Employees
  • EDSA N/A
  • SSKN N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SSKN Medical/Dental Instruments
  • Sector
  • EDSA Health Care
  • SSKN Health Care
  • Exchange
  • EDSA Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • EDSA 13.8M
  • SSKN 9.7M
  • IPO Year
  • EDSA N/A
  • SSKN 2005
  • Fundamental
  • Price
  • EDSA $2.08
  • SSKN $2.33
  • Analyst Decision
  • EDSA Strong Buy
  • SSKN Strong Buy
  • Analyst Count
  • EDSA 2
  • SSKN 1
  • Target Price
  • EDSA $13.00
  • SSKN $6.00
  • AVG Volume (30 Days)
  • EDSA 15.0K
  • SSKN 13.7K
  • Earning Date
  • EDSA 08-08-2025
  • SSKN 08-13-2025
  • Dividend Yield
  • EDSA N/A
  • SSKN N/A
  • EPS Growth
  • EDSA N/A
  • SSKN N/A
  • EPS
  • EDSA N/A
  • SSKN N/A
  • Revenue
  • EDSA N/A
  • SSKN $33,620,000.00
  • Revenue This Year
  • EDSA N/A
  • SSKN $3.31
  • Revenue Next Year
  • EDSA N/A
  • SSKN $9.67
  • P/E Ratio
  • EDSA N/A
  • SSKN N/A
  • Revenue Growth
  • EDSA N/A
  • SSKN 3.30
  • 52 Week Low
  • EDSA $1.55
  • SSKN $2.10
  • 52 Week High
  • EDSA $5.59
  • SSKN $3.80
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.28
  • SSKN 47.44
  • Support Level
  • EDSA $1.99
  • SSKN $2.26
  • Resistance Level
  • EDSA $2.11
  • SSKN $2.89
  • Average True Range (ATR)
  • EDSA 0.11
  • SSKN 0.17
  • MACD
  • EDSA 0.02
  • SSKN 0.02
  • Stochastic Oscillator
  • EDSA 72.41
  • SSKN 18.84

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: